Clinical Trial Update: Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for PEER Interactive evaluating safety and efficacy in depression has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PEER Interactive

Snippet

Sponsor: MYnd Analytics | Conditions: Depression | Phase 2, Phase 3 | Status: SUSPENDED